65202-50-8, In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 65202-50-8, name is Methyl 6-chloropyridazine-3-carboxylate, introducing its new discovery.
INHIBITORS OF JANUS KINASES
The instant invention provides for compounds that inhibit the four known mammalian JAK kinases (JAK1, JAK2, JAK3 and TYK2) and PDK1. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting the activity of JAK1, JAK2, JAK3, TYK2 and PDK1 by administering the compound to a patient in need of treatment for myeloproliferative disorders or cancer
Note that a catalyst decreases the activation energy for both the forward and the reverse reactions and hence accelerates both the forward and the reverse reactions.65202-50-8, you can also check out more blogs about65202-50-8
Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N2422 – PubChem